melanoma

Keytruda Becomes the First Anti-PD-1 Therapy Approved in China for Advanced Melanoma
CP Wire
Thu, 07/26/18 - 11:47 am
Merck
Keytruda
melanoma
China
Keytruda Becomes the First Anti-PD-1 Therapy Approved in China for Advanced Melanoma
Thu, 07/26/18 - 09:47 am
Merck
Keytruda
melanoma
Array wrestles FDA OK for its MEK/BRAF melanoma combo, to hit the pharmacy as Mektovi and Braftovi
Endpoints
Wed, 06/27/18 - 09:44 pm
Array Biopharma
binimetinib
Mektovi
Braftovi
melanoma
Nektar And Bristol Hurtle Forward With Experimental Cancer Drug
Forbes
Sun, 06/3/18 - 10:00 am
Nektar
Bristol-Myers Squibb
NKTR-214
ASCO 2018
melanoma
renal cell carcinoma
urothelial cancer
NeoImmuneTech and Roche Collaborate in Clinical Trial of HyLeukin-7 in Combination with a PD-L1 Checkpoint Inhibitor in Advanced High-Risk Skin Cancers
CP Wire
Wed, 05/2/18 - 09:58 am
NeoImmune Tech
Genexine
Roche
R&D
melanoma
Merkel cell carcinoma
cutaneous squamous cell carcinoma
NeoImmuneTech and Roche Collaborate in Clinical Trial of HyLeukin-7 in Combination with a PD-L1 Checkpoint Inhibitor in Advanced High-Risk Skin Cancers
Tue, 05/1/18 - 09:16 pm
NeoImmune Tech
Genexine
Roche
HyLeukin-7
checkpoint inhibitors
melanoma
Initial Ph II 2b Results of Elios' Personalized Cancer Vaccine for the Treatment of Melanoma Look Promising
CP Wire
Wed, 04/18/18 - 09:35 am
Elios Therapeutics
vaccines
melanoma
AACR
clinical trials
TLPLDC
Keytruda Adjuvant Therapy Study Shows Reduced the Risk of Disease Recurrence or Death by More Than 40 Percent Compared to Placebo in Stage III Melanoma
CP Wire
Sun, 04/15/18 - 01:54 pm
Merck
Keytruda
melanoma
anti-PD-1 immunotherapy
Keytruda Adjuvant Therapy Study Shows Reduced the Risk of Disease Recurrence or Death by More Than 40 Percent Compared to Placebo in Stage III Melanoma
Sun, 04/15/18 - 01:00 pm
Merck
Keytruda
melanoma
Wistar Researchers Find Combination Therapy Effective for NRAS Mutant and Therapy Resistant Melanoma
CP Wire
Thu, 04/12/18 - 11:59 am
melanoma
Wistar Institute
BET inhibitor
MEK inhibitor
Wistar Researchers Find Combination Therapy Effective for NRAS Mutant and Therapy Resistant Melanoma
Thu, 04/12/18 - 11:56 am
melanoma
MEK inhibitor
BET inhibitor
Incyte's stock plunges, Merck shares fall after disappointing study results of melanoma treatment
Marketwatch
Fri, 04/6/18 - 09:51 am
Incyte
Merck
melanoma
epacadostat
Keytruda
clinical trials
metastatic melanoma
FDA approves new dosing for Bristol-Myers Squibb's Opdivo
Yahoo/Reuters
Tue, 03/6/18 - 09:46 am
FDA
Bristol-Myers Squibb
Opdivo
dosing
cancer
melanoma
Merck’s melanoma drug shows early promise for resistant cancers in PhI trial
Endpoints
Sat, 02/24/18 - 10:21 am
Merck
melanoma
clinical trials
MK-8353
Array melanoma drugs show significant survival versus Roche drug in study
Reuters
Wed, 02/7/18 - 09:58 am
Array Biopharma
melanoma
Roche
encorafenib
binimetinib
Merck's Keytruda nabs new data to rival Bristol-Myers' Opdivo at fending off melanoma's return
Fierce Pharma
Mon, 01/15/18 - 10:37 am
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
melanoma
OncoSec shares turn hot as microcap reports promising PhII data for an I/O one-two punch
Endpoints
Wed, 11/8/17 - 10:18 am
OncoSec
clinical trials
ImmunoPulse IL-12
Keytruda
Merck
melanoma
Greek health minister takes issue with Roche’s withdrawal of cancer medicine due to mandatory discount
Endpoints
Tue, 10/31/17 - 09:18 pm
Roche
Greece
drug pricing
Cotellic
melanoma
OncoSec Seeks Accelerated Approval to Treat Melanoma
Yahoo/GuruFocus
Tue, 09/12/17 - 10:12 am
OncoSec
melanoma
ImmunoPulse(R) IL-12
devices
With Yervoy-beating data, Opdivo poised to fight melanoma's return after surgery
Fierce Pharma
Mon, 09/11/17 - 09:52 am
Yervoy
Opdivo
Bristol-Myers Squibb
melanoma

Pages